Pages that link to "Q28272415"
The following pages link to A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy (Q28272415):
Displaying 50 items.
- Follistatin gene delivery enhances muscle growth and strength in nonhuman primates (Q24598350) (← links)
- Drug treatment of Duchenne muscular dystrophy: available evidence and perspectives (Q24601770) (← links)
- Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting (Q24609841) (← links)
- Decreased specific force and power production of muscle fibers from myostatin-deficient mice are associated with a suppression of protein degradation (Q24632867) (← links)
- Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy (Q24647245) (← links)
- Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications (Q26775403) (← links)
- Facioscapulohumeral distrophy and physiotherapy: a literary review (Q26796651) (← links)
- Advancements in stem cells treatment of skeletal muscle wasting (Q26822437) (← links)
- Sarcopenic obesity: how do we treat it? (Q27011411) (← links)
- Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors (Q28069464) (← links)
- The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy (Q28592692) (← links)
- Facioscapulohumeral Dystrophy (Q30250223) (← links)
- Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics (Q30318405) (← links)
- Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials (Q31142754) (← links)
- Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody (Q31814859) (← links)
- Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice (Q33531816) (← links)
- Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model (Q33564220) (← links)
- Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review). (Q33608787) (← links)
- Activin A more prominently regulates muscle mass in primates than does GDF8. (Q33630598) (← links)
- The K153R polymorphism in the myostatin gene and muscle power phenotypes in young, non-athletic men. (Q33809137) (← links)
- Therapies for musculoskeletal disease: can we treat two birds with one stone? (Q33851441) (← links)
- Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy (Q33877924) (← links)
- An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease (Q33901722) (← links)
- Combination of myostatin pathway interference and dystrophin rescue enhances tetanic and specific force in dystrophic mdx mice (Q33931629) (← links)
- The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan (Q34080400) (← links)
- The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy (Q34106342) (← links)
- Optimal management of sarcopenia (Q34121822) (← links)
- Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials (Q34152280) (← links)
- Therapeutic developments in spinal muscular atrophy (Q34156272) (← links)
- Endurance exercise training in myostatin null mice (Q34291438) (← links)
- A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy. (Q34443876) (← links)
- Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques. (Q34486159) (← links)
- Preliminary investigation into a potential role for myostatin and its receptor (ActRIIB) in lean and obese horses and ponies (Q34497809) (← links)
- Ongoing developments in sporadic inclusion body myositis (Q34519540) (← links)
- Quadriceps myostatin expression in COPD (Q34575091) (← links)
- Mechanisms of muscle wasting in chronic kidney disease (Q34723810) (← links)
- Inhibition of Activin Receptor Type IIB Increases Strength and Lifespan in Myotubularin-Deficient Mice (Q34756083) (← links)
- Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy. (Q34756106) (← links)
- High throughput screening in duchenne muscular dystrophy: from drug discovery to functional genomics (Q34792390) (← links)
- Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease (Q34813421) (← links)
- Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. (Q34994545) (← links)
- Interventions for muscular dystrophy: molecular medicines entering the clinic (Q35014916) (← links)
- Follistatin Improves Skeletal Muscle Healing after Injury and Disease through an Interaction with Muscle Regeneration, Angiogenesis, and Fibrosis (Q35167976) (← links)
- The role of myostatin in muscle wasting: an overview (Q35223987) (← links)
- The effects of an ActRIIb receptor Fc fusion protein ligand trap in juvenile simian immunodeficiency virus-infected rhesus macaques (Q35410626) (← links)
- Long-Term Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Golden Retriever Muscular Dystrophy (Q35612576) (← links)
- Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing (Q35768143) (← links)
- Novel intriguing strategies attenuating to sarcopenia (Q35829811) (← links)
- Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy (Q35858791) (← links)
- Meeting Report: New Directions in the Biology and Disease of Skeletal Muscle 2014 (Q35869849) (← links)